相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure
Jonathan Z. Li et al.
AIDS (2012)
Incidence of HIV-1 Drug Resistance Among Antiretroviral Treatment-Naive Individuals Starting Modern Therapy Combinations
Viktor von Wyl et al.
CLINICAL INFECTIOUS DISEASES (2012)
Long-Lasting Protection of Activity of Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors (PIs) by Boosted PI Containing Regimens
Alexandra U. Scherrer et al.
PLOS ONE (2012)
Low-Frequency HIV-1 Drug Resistance Mutations and Risk of NNRTI-Based Antiretroviral Treatment Failure A Systematic Review and Pooled Analysis
Jonathan Z. Li et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study
Linda Wittkop et al.
LANCET INFECTIOUS DISEASES (2011)
Antiretroviral medication adherence and class-specific resistance in a large prospective clinical trial
Edward M. Gardner et al.
AIDS (2010)
Cohort Profile: The Swiss HIV Cohort Study
Franziska Schoeni-Affolter et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2010)
Molecular Epidemiology Reveals Long-Term Changes in HIV Type 1 Subtype B Transmission in Switzerland
Roger D. Kouyos et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Efficient Suppression of Minority Drug-Resistant HIV Type 1 (HIV-1) Variants Present at Primary HIV-1 Infection by Ritonavir-Boosted Protease Inhibitor-Containing Antiretroviral Therapy
Karin J. Metzner et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Antiretroviral medication adherence and the development of class-specific antiretroviral resistance
Edward M. Gardner et al.
AIDS (2009)
Minority Quasispecies of Drug-Resistant HIV-1 That Lead to Early Therapy Failure in Treatment-Naive and -Adherent Patients
Karin J. Metzner et al.
CLINICAL INFECTIOUS DISEASES (2009)
The Combined Effect of Modern Highly Active Antiretroviral Therapy Regimens and Adherence on Mortality Over Time
Viviane D. Lima et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Detection of nonnucleoside reverse-transcriptase inhibitor-resistant HIV-1 after discontinuation of virologically suppressive antiretroviral therapy
C. Bradley Hare et al.
CLINICAL INFECTIOUS DISEASES (2008)
The Relationship Between Resistance and Adherence in Drug-Naive Individuals Initiating HAART Is Specific to Individual Drug Classes
Lily W. Y. Tam et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2008)
Episodic antiretroviral therapy increases HIV transmission risk compared with continuous therapy: Results of a randomized controlled trial
William Burman et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2008)
Forgiveness of non-adherence to HIV-1 antiretroviral therapy
Jonathan Shuter
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Inferior clinical outcome of the CD4+ cell count guided antiretroviral treatment interruption strategy in the SMART study:: Role of CD4+ cell counts and HIV RNA levels during follow-up
Jens D. Lundgren et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Transmission of HIV-1 drug resistance in Switzerland:: a 10-year molecular epidemiology survey
Sabine Yerly et al.
AIDS (2007)
Emergence of HIV-1 drug resistance in previously untreated patients initiating combination Antiretroviral treatment -: A comparison of different regimen types
Viktor Von Wyl et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes
Jean B. Nachega et al.
ANNALS OF INTERNAL MEDICINE (2007)
Repeated measures longitudinal analyses of HIV virologic response as a function of percent adherence, dose timing, genotypic sensitivity, and other factors
HH Liu et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2006)
Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV
JE Gallant et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness
DR Bangsberg et al.
AIDS (2006)
Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death:: a prospective cohort study
JAC Sterne et al.
LANCET (2005)
Relationship between adherence and the development of resistance in antiretroviral-naive, HIV-1-infected patients receiving lopinavir/ritonavir or nelfinavir
MS King et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
HIV-1 drug resistance: Degree of underestimation by a cross-sectional versus a longitudinal testing approach
PR Harrigan et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Modeling the HIV protease inhibitor adherence-resistance curve by use of empirically derived estimates
DR Bangsberg et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Predictors of virologic failure and resistance in HIV-Infected patients treated with nevirapineor efavirenz-based antiretroviral therapy
JJ Parienti et al.
CLINICAL INFECTIOUS DISEASES (2004)
Paradoxes of adherence and drug resistance to HIV antiretroviral therapy
DR Bangsberg et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance
AK Sethi et al.
CLINICAL INFECTIOUS DISEASES (2003)
High levels of adherence do not prevent accumulation of HIV drug resistance mutations
DR Bangsberg et al.
AIDS (2003)
Drug resistance in patients experiencing early virological failure under a triple combination including indinavir
O Gallego et al.
AIDS (2001)
Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission
JB Jackson et al.
AIDS (2000)
分享论文
